BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,593,000 | -13.8% | 19,805 | -7.7% | 0.09% | -13.0% |
Q2 2020 | $1,847,000 | +6.6% | 21,448 | +0.5% | 0.10% | -5.7% |
Q1 2020 | $1,732,000 | -5.4% | 21,331 | -2.6% | 0.11% | +20.5% |
Q4 2019 | $1,831,000 | -56.6% | 21,891 | -54.6% | 0.09% | -58.9% |
Q3 2019 | $4,222,000 | -1.5% | 48,269 | -7.8% | 0.21% | +0.9% |
Q2 2019 | $4,287,000 | -70.7% | 52,344 | -70.9% | 0.21% | -69.3% |
Q1 2019 | $14,649,000 | +9.5% | 180,167 | -11.3% | 0.69% | +1.8% |
Q4 2018 | $13,372,000 | -25.3% | 203,156 | -12.5% | 0.68% | -7.2% |
Q3 2018 | $17,905,000 | -50.6% | 232,267 | -52.7% | 0.73% | -53.9% |
Q2 2018 | $36,266,000 | +6.2% | 491,140 | -6.4% | 1.59% | +3.3% |
Q1 2018 | $34,137,000 | -3.9% | 524,865 | -4.5% | 1.54% | -0.5% |
Q4 2017 | $35,536,000 | +1.1% | 549,759 | -1.9% | 1.55% | -4.6% |
Q3 2017 | $35,151,000 | +4.0% | 560,177 | +0.3% | 1.62% | +2.0% |
Q2 2017 | $33,800,000 | +109.1% | 558,309 | +79.1% | 1.59% | +110.9% |
Q1 2017 | $16,163,000 | – | 311,669 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |